Bruce Kovner, Director, 10% Owner at SYNTA PHARMACEUTICALS CORP (SNTA), bought 500,000 shares at $4.35 ($2.3M) on 2013-06-25, disclosed to the SEC on 2013-06-27.
Open-market purchase of $2.3M SNTA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.35 | 200,000 | $870K | 38.4% |
| 2 | $4.65 | 300,000 | $1.4M | 61.6% |
| Total | $4.53 avg | 500,000 | $2.3M | 100% |
| Filing → |
| SBBP | BUY | 2018-12-21 | $1.3M | — | Filing → |
| SBBP | BUY | 2018-08-09 | $3.6M | — | Filing → |
| SBBP | BUY | 2018-07-27 | $2.6M | — | Filing → |